Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/399584

Detecting overlapping spatial clusters of high sugar-sweetened beverage intake and high body mass index in a general population: a cross-sectional study

Joost, S.·De Ridder, D.·Marques-Vidal, P.·Bacchilega, B.·Theler, J.-M.·Gaspoz, J.-M.·Guessous, I.
View original source ↗Export metadata ↓

Abstract

ObjectiveTo identify populations and areas presenting higher consumption of sugar-sweetened beverages (SSB) and their overlap with populations and areas presenting higher body mass index (BMI).\n\nDesignCross-sectional population-based study.\n\nSettingState of Geneva, Switzerland.\n\nParticipants15,767 non-institutionalized residents aged between 35 and 74 years (20 and 74 since 2011) of the state of Geneva, Switzerland.\n\nMain outcome measuresSpatial indices of sugar-sweetened beverage intake frequency and body mass index. Median regression analysis was used to control for characteristics of patients.\n\nResultsThe SSB intake frequency and the BMI were not randomly distributed across the state. Among the 15,423 participants retained for the analyses, 2,034 (13.2%) were within clusters of high SSB intake frequency and 1,651 (10.7%) was within clusters of low SSB intake frequency, 11,738 (76.1%) showed no spatial dependence. We also identified clusters of BMI, 4,014 (26.0%) participants were within clusters of high BMI and 3,591 (23.3%) were within clusters of low BMI, 7,818 (50.7%) showed no spatial dependence. We found that clusters of SSB intake frequency and BMI overlap in specific areas. 1,719 (11.1%) participants were within high SSB intake frequency and high BMI clusters. After adjustment for covariates (education level, gender, age, nationality, and the median income of the area), the identified clusters persisted and were only slightly attenuated.\n\nConclusionA fine-scale spatial approach allows identifying specific populations and areas presenting higher SSB consumption and, for some areas, higher SSB consumption associated with higher BMI. These findings could guide legislators to develop targeted interventions such as prevention campaigns and pave the way for precision public health.\n\nWhat is already known on this topicO_LIThe consumption of sugar-sweetened beverages (SSBs) is an important contributory factor of obesity and obesity-related diseases.\nC_LIO_LISSB consumption varies according to socioeconomic status, which could explain the higher prevalence of obesity in specific areas.\nC_LIO_LISSB taxation faces resistance in many countries due to its potential regressive nature.\nC_LI\n\nWhat this study addsO_LIThe spatial analysis of individual-level SSB consumption in the state of Geneva provides a clear identification of populations and areas presenting higher SSB consumption and, for some areas, higher SSB consumption along with higher body mass index (BMI).\nC_LIO_LIThe results demonstrate the persistence of SSB clustering in the geographic space after adjusting for education level, gender, nationality, age, and neighborhood-level median income.\nC_LIO_LIThe findings provide guidance for future public health interventions to reduce SSB consumption by better targeting vulnerable populations.\nC_LI

Explore related subjects

epidemiologyPreprint

Keep this discovery

BibTeXRIS

Joost, S., De Ridder, D., Marques-Vidal, P., Bacchilega, B., Theler, J.-M., Gaspoz, J.-M., Guessous, I.. 2018-08-29. Detecting overlapping spatial clusters of high sugar-sweetened beverage intake and high body mass index in a general population: a cross-sectional study. https://doi.org/10.1101/399584

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2018

Translating surveillance data into incidence estimates

Monitoring a population for a disease requires the hosts to be sampled and tested for the pathogen. This results in sampling series from which to estimate the disease incidence, i.e. the proportion of hosts infected. Existing estimation methods assume that disease incidence is not changing between monitoring rounds, resulting in underestimation of the disease incidence. In this paper we develop an incidence estimation model accounting for epidemic growth with monitoring rounds sampling varying incidence. We also show how to accommodate the asymptomatic period characteristic to most diseases. For practical use, we produce an approximation of the model, which is subsequently shown accurate for relevant epidemic and sampling parameters. Both the approximation and the full model are applied to stochastic spatial simulations of epidemics. The results prove their consistency for a very wide range of situations.

epidemiology↗
bioRxiv2018

The Swiss Primary Ciliary Dyskinesia registry: objectives, methods and first results

Primary Ciliary Dyskinesia (PCD) is a rare hereditary, multi-organ disease caused by defects in ciliary structure and function. It results in a wide range of clinical manifestations, most commonly in the upper and lower airways. Central data collection in national and international registries is essential to studying the epidemiology of rare diseases and filling in gaps in knowledge of diseases such as PCD. For this reason, the Swiss Primary Ciliary Dyskinesia Registry (CH-PCD) was founded in 2013 as a collaborative project between epidemiologists and adult and paediatric pulmonologists.\n\nThe registry records patients of any age, suffering from PCD, who are treated and resident in Switzerland. It collects information from patients identified through physicians, diagnostic facilities, and patient organisations. The registry dataset contains data on diagnostic evaluations, lung function, microbiology and imaging, symptoms, treatments, and hospitalizations.\n\nBy May 2018, CH-PCD has contacted 566 physicians of different specialties and identified 134 patients with PCD. At present this number represents an overall 1 in 63,000 prevalence of people diagnosed with PCD in Switzerland. Prevalence differs by age and region; it is highest in children and adults younger than 30 years, and in Espace Mittelland. The median age of patients in the registry is 25 years (range 5-73), and 49 patients have a definite PCD diagnosis based on recent international guidelines. Data from CH-PCD are contributed to international collaborative studies and the registry facilitates patient identification for nested studies.\n\nCH-PCD has proven to be a valuable research tool that already has highlighted weaknesses in PCD clinical practice in Switzerland. Development of centralised diagnostic and management centres and adherence to international guidelines are needed to improve diagnosis and management--particularly for adult PCD patients.

epidemiology↗
bioRxiv2018

Perfect Counterfactuals for Epidemic Simulations

Simulation studies are often used to predict the expected impact of control measures in infectious disease outbreaks. Typically, two independent sets of simulations are conducted, one with the intervetnion, and one without, and epidemic sizes (or some related metric) are compared to estimate the effect of the intervention. Since it is possible that controlled epidemics are larger than uncontrolled ones if there is substantial stochastic variation between epidemics, uncertainty intervals from this approach can include a negative effect even for an effective intervention. To more precisely estimate the number of cases an intervention will prevent within a single epidemic, here we develop a single world approach to matching simulations of controlled epidemics to their exact uncontrolled counterfac-tual. Our method borrows concepts from percolation approaches prune out possible epidemic histories and create potential epidemic graph that can be realized to create perfectly matched controlled and uncontrolled epidemics. We present an implementation of this method for a common class of compartmental models, and its application in a simple SIR model. Results illustrate how, at the cost of some computation time, this method substantially narrows confidence intervals and avoids non-sensical inferences.

epidemiology↗